EFFICACY AND SAFETY OF DUPILUMAB MONOTHERAPY IN CHINESE ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: RATIONALE AND DESIGN OF A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED PHASE III TRIAL

被引：0

作者：

Zhao, Yan ^{[1
]}

Lu, Qianjin ^{[2
]}

Gao, Xinghua ^{[3
]}

Liu, Lingling ^{[4
]}

Li, Wei ^{[5
]}

Song, Zhiqiang ^{[6
]}

Yao, Zhirong ^{[7
]}

Yao, Xu ^{[8
]}

Hao, Nan ^{[9
]}

Zhang, Jianzhong ^{[1
]}

机构：

[1] Peking Univ, Peoples Hosp, Dept Dermatol, Beijing, Peoples R China

[2] Cent South Univ, Xiangya Hosp 2, Dept Dermatol, Hunan Key Lab Med Epigenom, Changsha, Hunan, Peoples R China

[3] China Med Univ, Hosp 1, NHC Key Lab Immunodermatol, Minist Educ,Key Lab Immunodermatol,Dept Dermatol, Shenyang, Peoples R China

[4] Peking Univ First Hosp, Dept Dermatol, Beijing, Peoples R China

[5] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai, Peoples R China

[6] Third Mil Med Univ, Southwest Hosp, Dept Dermatol, Chongqing, Peoples R China

[7] Shanghai Jiao Tong Univ, Xin Hua Hosp, Sch Med, Dept Dermatol, Shanghai, Peoples R China

[8] Chinese Acad Med Sci & Peking Union Med Coll, Inst Dermatol, Nanjing, Peoples R China

[9] Sanofi, Med Dept, Shanghai, Peoples R China

来源：

ACTA DERMATO-VENEREOLOGICA | 2021年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

PT4

引用

页码：52 / 53

页数：2

共 50 条

[1] Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: results from two phase III, randomized, double-blinded, placebo-controlled trials
Silverberg, Jonathan I.
Thaci, Diamant
Seneschal, Julien
Gold, Linda Stein
Blauvelt, Andrew
Simpson, Eric
Chu, Chia-Yu
Liu, Zhuqing T.
Lima, Renata Gontijo
Pillai, Sreekumar
Guttman-Yassky, Emma
BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E97 - E98
[2] The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study
Zhao, Y.
Wu, L.
Lu, Q.
Gao, X.
Zhu, X.
Yao, X.
Li, L.
Li, W.
Ding, Y.
Song, Z.
Liu, L.
Dang, N.
Zhang, C.
Liu, X.
Gu, J.
Wang, J.
Geng, S.
Liu, Q.
Guo, Y.
Dong, L.
Su, H.
Bai, L.
O'Malley, J. T.
Luo, J.
Laws, E.
Mannent, L.
Ruddy, M.
Amin, N.
Bansal, A.
Ota, T.
Wang, M.
Zhang, J.
BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : 633 - 641
[3] Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
Blauvelt, Andrew
Thyssen, Jacob P.
Guttman-Yassky, Emma
Bieber, Thomas
Serra-Baldrich, Esther
Simpson, Eric
Rosmarin, David
Elmaraghy, Hany
Meskimen, Eric
Natalie, Chitra R.
Liu, Zhuqing
Xu, Chenjia
Pierce, Evangeline
Morgan-Cox, MaryAnn
Gil, Esther Garcia
Silverberg, Jonathan, I
BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (06) : 740 - 748
[4] Efficacy and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: Results from Two Phase 3, Randomized, Double-Blinded, Placebo-Controlled Trials
Silverberg, Jonathan
Thaci, Diamant
Seneschal, Julien
Gold, Linda Stein
Blauvelt, Andrew
Simpson, Eric
Chu, Chia-Yu
Liu, Zhuqing
Lima, Renata Gontijo
Pillai, Sreekumar
Guttman-Yassky, Emma
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 62 - 62
[5] EFFICACY AND SAFETY OF DUPILUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN CHINESE ADULTS: A MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIAL
Zhao, Yan
Wu, Liming
Lu, Qianjin
Gao, Xinghua
Zhu, Xiaohong
Yao, Xu
Li, Linfeng
Li, Wei
Ding, Yangfeng
Song, Zhiqiang
Liu, Lingling
Dang, Ningning
Zhang, Chunlei
Liu, Xiaoming
Gu, Jun
Wang, Jinyan
Geng, Songhai
Liu, Qunazhong
Guo, Yifeng
Lv, Dong
Ren, Gong
Yang, Xiumin
Deng, Danqi
Li, Shanshan
Han, Xiuping
Biao, Shuzhen
Zheng, Min
Dong, Li
Su, Huijuan
Bai, Lili
O'Malley, John T.
Luo, Junxiang
Zhang, Jianzhong
ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 58 - 58
[6] Dupilumab for adolescents with moderate-to-severe atopic dermatitis: Results from a phase 3, randomized, double-blinded trial
Paller, A.
Blauvelt, A.
Pariser, D.
Worrell, R.
Soong, W.
Hong, C.
Zhang, R.
Eckert, L.
Gadkari, A.
Hultsch, T.
Bansal, A.
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 69 - 69
[7] Dupilumab for Adolescents With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 3, Randomized, Double-Blinded Trial
Paller, A.
Blauvelt, A.
Pariser, D.
Soong, W.
Hong, H. C-H
Zhang, R.
Eckert, L.
Gadkari, A.
Hultsch, T.
Bansal, A.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 116 - 116
[8] Dupilumab for adolescents with moderate-to-severe atopic dermatitis: Results from a phase 3, randomized, double-blinded trial
Paller, Amy S.
Blauvelt, Andrew
Pariser, David M.
Soong, Wiley
Hong, H. Chih-ho
Zhang, Rick
Eckert, Laurent
Gadkari, Abhijit
Hultsch, Thomas
Bansal, Ashish
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB195 - AB195
[9] Safety and efficacy of upadacitinib monotherapy in adolescents and adults with moderate-to-severe atopic dermatitis: results from two pivotal, phase III, randomized, double-blinded, monotherapy, placebo-controlled studies (Measure Up 1 and Measure Up 2)
Guttman-Yassky, E.
Teixeira, H. D.
Simpson, E. L.
Papp, K. A.
Pangan, A. L.
Blauvelt, A.
Thaci, D.
Chu, C. Y.
Hong, H. C.
Katoh, N.
Paller, A. S.
Calimlim, B.
Gu, Y.
Hu, X.
Liu, M.
Yang, Y.
Tenorio, A. R.
Chu, A. D.
Irvine, A. D.
BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E62 - E62
[10] Dupilumab Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study
Bieber, Thomas R. M.
Thaci, Diamant
Graham, Neil
Pirozzi, Gianluca
Teper, Ariel
Ren, Haobo
Radin, Allen
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB404 - AB404

← 1 2 3 4 5 →